CBL and diabetes mellitus: Taken altogether, Cbl inhibited the expression of Runx3 by inhibiting the activation of the JAK2/STAT4 pathway, and activated NO production, ultimately inhibiting HUVEC apoptosis in the aorta of DM rats.